Lessons Learned from Newborn Screening for Pompe Disease and Mucopolysaccharidosis Type I: Early Intervention Influences Outcomes
This live activity will feature 3 expert faculty and be delivered in a dynamic plenary and case-based format to maximize interactivity, engagement, and retention.
- Discuss the phenotype spectrum of Pompe Disease and MPS I
- Analyze the diagnostic algorithm for Pompe Disease following a positive newborn screen
- Review treatment approaches for Pompe Disease and the importance of early initiation of treatment
- Analyze the diagnostic algorithm for MPS I following a positive newborn screen
- Review treatment approaches for MPS I and the importance of early initiation of treatment
Professor of Pediatrics and Genetics
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Barbara K. Burton, MD
Professor of Pediatrics
Feinberg School of Medicine
Division of Genetics,
Birth Defects and Metabolism
Ann & Robert H. Lurie
Children’s Hospital of Chicago
Priya S. Kishnani, MD
C.L. and Su Chen Professor of Pediatrics
Department of Pediatrics
Division of Medical Genetics
Duke University Medical Center
Durham, North Carolina
Clinical Professor of Human Genetics
Medical Director, Human Genetics
Pritzker School of Medicine
The University of Chicago
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Miller Medical Communications, LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.